LOADING
Tag: RampD
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation – simplywall.st
February 4, 2026
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation simplywall.st Source link
chat_bubble0 Comment
visibility54 Views
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities – simplywall.st
January 31, 2026
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities simplywall.st Source link
chat_bubble0 Comment
visibility58 Views
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution – The Globe and Mail
November 22, 2025
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution The Globe and Mail Source link
chat_bubble0 Comment
visibility51 Views